Nexus Pharmaceuticals Inc
General
Total Cases27
Active Cases7
Patents--
Ratings
Experience
Grade
Trend
DCT
L2
D
PTAB
L2
D
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 01/07/25 | Summons Issued as to Hikma Pharmaceuticals PLC on 1/6/2025; Hikma Pharmaceuticals USA Inc. on 1/6/2025. (Attachments: # [1] Summons Issued)(oam) (Entered: 01/07/2025) | |
| 01/07/25 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nexus Family Holdings, Inc. for Nexus Pharmaceuticals, LLC filed by Nexus Pharmaceuticals, LLC. (oam) (Entered: 01/07/2025) | |
| 01/07/25 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,464,752 B2; 11,426,369 B2; 11,571,398 B1. (oam) (Entered: 01/07/2025) | |
| 01/07/25 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 01/07/2025) | |
| 01/07/25 | COMPLAINT with Jury Demand against Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals USA Inc. (Filing fee $ 405, receipt number ADEDC-4583298) - filed by Nexus Pharmaceuticals, LLC. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Exhibit C, # [4] Exhibit D, # [5] Civil Cover Sheet)(oam) (Entered: 01/07/2025) | |
| 12/16/24 | MINUTE entry before the Honorable Mary M. Rowland: Plaintiffs' motion for leave to withdraw Attorney Chidambaram S. Iyer as counsel [149] is granted. Attorney Iyer terminated as counsel of record for Plaintiffs. Mailed notice. (exr, ) (Entered: 12/16/2024) | |
| 12/13/24 | MINUTE entry before the Honorable Mary M. Rowland: Defendant's motion to file under seal [131] is granted. Docket entries [134] , [135] , [139] , [141] to remain under seal. Plaintiff's motion to filed under seal [136] is granted. Docket entries [142] , [143] , [144] , [145] to remain under seal. Mailed notice. (jg, ) (Entered: 12/13/2024) | |
| 12/13/24 | MOTION by Plaintiffs Ingenus Pharmaceuticals, LLC, Leiutis Pharmaceuticals LLP, Counter Defendants Ingenus Pharmaceuticals, LLC, Leiutis Pharmaceuticals LLP to withdraw Chidambaram S. Iyer as Counsel for Plaintiffs Presented before District Judge (Griffith, Christopher) (Entered: 12/13/2024) | |
| 12/12/24 | MINUTE entry before the Honorable Daniel P. McLaughlin: Defendant's motion to file under seal [146] is granted. Defendant's reply in support of its motion to compel [147] may be filed under seal. Mailed notice(maf) (Entered: 12/12/2024) | |
| 12/11/24 | SEALED REPLY by Nexus Pharmaceuticals, Inc. to SEALED MOTION by Defendant Nexus Pharmaceuticals, Inc. Motion to Compel Production of Documents Presented before Magistrate Judge [116] (Patel, Sailesh) (Entered: 12/11/2024) |